- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05314478
Headgear Accessory for Exercise-Induced Laryngeal Obstruction Studies (HALOS)
Safe and Effective Headgear Accessory for Exercise-Induced Laryngeal Obstruction Studies (HALOS) - a Device Development Study
Exercise-induced laryngeal obstruction (EILO) is a condition in which the larynx, or voice box, narrows during high-intensity exercise, and is often mis-diagnosed. A test called a Continuous Laryngoscopy during Exercise (CLE) test can be performed, where a flexible camera is inserted through the nose and positioned at the back of the throat. While the patient exercises, the camera image can be used to identify the presence of EILO.
During the CLE test it is important that the part of the camera that remains outside the body is held securely in position near the forehead so that a clear and stable image is obtained using a headgear to secure the camera to the patient's head.
There are no headgears available on the market, so we have designed and manufactured one called HALOS (Headgear Accessory for Exercise-Induced Laryngeal Obstruction Studies).
This study is to ensure that HALOS is suitable for use, and to check we have understood and minimised the risks associated with the headgear. The headgear can then be used routinely within the Trust, improving the care that offered to patients.
We will recruit 30 male or female participants who need to undergo a CLE test. The study will be conducted at Broadgreen Hospital, Liverpool, UK. Before the CLE test, participants will attend a screening appointment to discuss the procedure. There will be no follow-up appointments.
During the CLE test, the participants will wear the HALOS headgear while exercising, and the clinician will monitor the image from the camera for signs of EILO. After the test, participants will be asked how tolerable the headgear was, and if they have any concerns about any aspect of it. The clinician will also record how clear and stable the camera image was, how easy it was to use, and any concerns about any aspect of it.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Merseyside
-
Liverpool, Merseyside, United Kingdom, L7 8XP
- Liverpool University Hospitals NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participant is willing and able to give informed consent for participation in the study.
- Male, female or non-binary, aged 18 years or above.
- Able (in the Investigators opinion) and willing to comply with all study requirements.
- Able to undergo a CLE test as judged by the clinician, and where a clinical need of the test for the delivery of healthcare has been identified.
Exclusion Criteria:
- Pain, sore areas, broken skin at the site of contact with the headgear.
- Devices, e.g. cochlear implants, that impede the use of the headgear.
- Head circumference is less than 50cm or greater than 63cm, reflecting the 3rd centile for females and 97th centile for males, respectively (Bushby, 1992).
Exclusion criteria for endoscopy procedures:
- Skull base/facial surgery or fracture within the previous six weeks
- Major or life threatening epistaxis within the previous six weeks
- Trauma to nasal cavity secondary to surgery or injury within the previous six weeks
- Sino-nasal and anterior skull base tumours/surgery
- Nasopharyngeal stenosis
- Craniofacial anomalies
- Hereditary haemorrhagic telangiectasia
- Severe movement disorders and/or severe agitation
- Vasovagal history
- Bleeding risks
- Any other exclusion criteria as identified by the current endoscopy procedure.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Participants
Participants will be required to attend a single consultation and screening appointment to discuss the investigation procedure, and this will occur at least a week before the Continuous Laryngoscopy during Exercise (CLE) test.
Participants will then attend one appointment for the CLE test.
There will be no follow up assessments using the headgear.
|
The participant will undergo the CLE test following standard clinical practice. The order of events of the aspects of the investigation related to the headgear will be:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Participants With Continuous Laryngoscopy During Exercise Tests
Time Frame: 30 minutes
|
The percentage of participants with continuous laryngoscopy during exercise tests where the endoscopy image was clear and stable enough to allow a diagnosis of exercise-induced laryngeal obstruction to be confirmed or ruled out.
|
30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Participants With Device Usability Rating of 4 or 5
Time Frame: 60 minutes
|
The percentage of participants where the clinician provided a device usability rating of 4 or 5 on the post-test questionnaire.
Device usability is scored on a five-point LIKERT scale ranging from 1 (very hard to use) to 5 (very easy to use).
|
60 minutes
|
|
Device Usability Subjective Feedback
Time Frame: 60 minutes
|
Focussing on any clinician-reported concerns regarding set-up, operation and cleaning.
|
60 minutes
|
|
Percentage of Participants Scoring Device Tolerability as 3 or 4
Time Frame: 60 minutes
|
The percentage of participants where the participant provided a device tolerability rating of 3 or 4 on the post-test questionnaire.
Device tolerability is scored on a four-point scale of 1 (highly intolerable), 2 (intolerable), 3 (tolerable) or 4 (highly tolerable).
|
60 minutes
|
|
Device Tolerability Subjective Feedback
Time Frame: 60 minutes
|
Focussing on any participant-reported concerns regarding the comfort of the headgear including how hot their head felt, weight of the headgear, how secure the headgear felt and the impact of the headgear on their performance during the investigation.
|
60 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: Tristan Payne, Liverpool University Hospitals NHS Foundation Trust
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SP0707
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise-Induced Laryngeal Obstruction
-
Haukeland University HospitalCompletedExercise Induced Laryngeal Obstruction (EILO)Norway
-
Bispebjerg HospitalRecruitingExercise-induced Laryngeal Obstruction (EILO)Denmark
-
Cook Children's Health Care SystemNot yet recruitingExercise-Induced Laryngeal Obstruction | Dyspnea During ActivityUnited States
-
Haukeland University HospitalRecruiting
-
VID Specialized UniversityNorwegian School of Sport SciencesCompletedExercise Induced Laryngeal Obstruction (EILO)Norway
-
Medisch Spectrum TwenteHaukeland University HospitalNot yet recruitingAsthma in Children | Larynx | Dyspnea | Exercise-Induced Bronchoconstriction | Exercise-Induced Bronchospasm | Exercise Induced Laryngeal ObstructionNetherlands
-
University of BernRecruitingCough | Asthma | Dysfunctional Breathing | Wheezing | Exercise Induced Bronchospasm | Inspiratory Laryngeal ObstructionSwitzerland, Austria
-
Indiana UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD); Purdue... and other collaboratorsRecruitingVocal Cord Dysfunction | Paradoxical Vocal Fold Motion | Exercise-Induced Vocal Cord DysfunctionUnited States
-
Appalachian State UniversityDole Food CompanyCompletedExercise-induced Inflammation | Exercise-induced Oxidative Stress | Exercise-induced Immune DysfunctionUnited States
-
Norwegian University of Science and TechnologyKlinikk for allergi og luftveissykdommerCompletedExercise Induced BronchoconstrictionNorway
Clinical Trials on Continuous laryngoscopy during exercise test using the HALOS headgear
-
Helsinki University Central HospitalWithdrawnLarynx | Obstruction | Vocal Cord DysfunctionFinland
-
Medisch Spectrum TwenteHaukeland University HospitalNot yet recruitingAsthma in Children | Larynx | Dyspnea | Exercise-Induced Bronchoconstriction | Exercise-Induced Bronchospasm | Exercise Induced Laryngeal ObstructionNetherlands
-
Bispebjerg HospitalRecruitingExercise-induced Laryngeal Obstruction (EILO)Denmark
-
Rambam Health Care CampusThe Baruch Padeh Medical Center, PoriyaRecruitingCOVID-19 | MIS-C Associated With COVID-19Israel
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPregnancy Related | HIV Prevention | Pre-exposure ProphylaxisMalawi
-
Brunel UniversityUniversity of Sao PauloUnknownBreathlessness | Hyperventilation Syndrome | Respiration Disorder | Breath ShortnessUnited Kingdom
-
Jorge Torres MejíasEnrolling by invitationChanges in the Intestinal Microbiota Under Hypobaric Hypoxia Conditions | Changes in Blood Glucose Under Hypobaric Hypoxia Conditions | Changes in Body Composition Under Hypobaric Hypoxia Conditions | Determination of Physiological Stress in Hypobaric HypoxiaChile
-
Jaeb Center for Health ResearchActive, not recruitingCystic FibrosisUnited States